Cholesterol depletion of hepatoma cells impairs hepatitis B virus envelopment by altering the topology of the large envelope protein

Journal of Virology

Volumn 85, Issue 24, 2011, Pages 13373-13383

  Dorobantu, Cristina ^a   Macovei, Alina ^a   Lazar, Catalin ^a   Dwek, Raymond A ^b   Zitzmann, Nicole ^b   Branza Nichita, Norica ^a  

^a INSTITUTE OF BIOCHEMISTRY OF THE ROMANIAN ACADEMY   (Romania)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MEVINOLIN; NUCLEOCAPSID PROTEIN; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ARTICLE; CONTROLLED STUDY; DEPLETION; ENDOCYTOSIS; ENZYME INHIBITION; HEPATITIS B VIRUS; HEPATOMA CELL; IMMUNOPRECIPITATION; LONG TERM EXPOSURE; MICROSOME MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; VIRION; VIROGENESIS; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS CELL TRANSFORMATION; VIRUS ENVELOPE; VIRUS GENOME; VIRUS PARTICLE; VIRUS RELEASE; VIRUS REPLICATION;

CELL LINE; CHOLESTEROL; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; VIRAL ENVELOPE PROTEINS; VIRUS ASSEMBLY; VIRUS RELEASE; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 84855826018     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05423-11     Document Type: Article

References (50)

1. Aizaki, H., et al. 2008. Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J. Virol. 82:5715-5724.
2. Aloia, R. C., H. Tian, and F. C. Jensen. 1993. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl. Acad. Sci. U. S. A. 90:5181-5185.
3. Bastiaanse, E. M., K. M. Hold, and A. Van der Laarse. 1997. The effect of membrane cholesterol content on ion transport processes in plasma membranes. Cardiovasc. Res. 33:272-283.
4. Bavari, S., et al. 2002. Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J. Exp. Med. 195:593-602.
5. Bozza, P. T., K. G. Magalhaes, and P. F. Weller. 2009. Leukocyte lipid bodies-biogenesis and functions in inflammation. Biochim. Biophys. Acta 1791:540-551.
6. Bremer, C. M., C. Bung, N. Kott, M. Hardt, and D. Glebe. 2009. Hepatitis B virus infection is dependent on cholesterol in the viral envelope. Cell. Microbiol. 11:249-260.
7. Bruss, V. 2007. Hepatitis B virus morphogenesis. World J. Gastroenterol. 13:65-73.
8. Bruss, V., and K. Vieluf. 1995. Functions of the internal pre-S domain of the large surface protein in hepatitis B virus particle morphogenesis. J. Virol. 69:6652-6657.
9. Buhaescu, I., and H. Izzedine. 2007. Mevalonate pathway: a review of clinical and therapeutical implications. Clin. Biochem. 40:575-584.
10. Campbell, S. M., S. M. Crowe, and J. Mak. 2001. Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. J. Clin. Virol. 22:217-227.
11. Chappell, D. A., G. L. Fry, M. A. Waknitz, and J. J. Berns. 1991. Ligand size as a determinant for catabolism by the low density lipoprotein (LDL) receptor pathway. A lattice model for LDL binding. J. Biol. Chem. 266:19296-19302.
12. Chattopadhyay, A., M. Jafurulla, S. Kalipatnapu, T. J. Pucadyil, and K. G. Harikumar. 2005. Role of cholesterol in ligand binding and G-protein coupling of serotonin1A receptors solubilized from bovine hippocampus. Biochem. Biophys. Res. Commun. 327:1036-1041.
13. Corbett, E. F., et al. 2000. The conformation of calreticulin is influenced by the endoplasmic reticulum luminal environment. J. Biol. Chem. 275:27177-27185.
14. Dane, D. S., C. H. Cameron, and M. Briggs. 1970. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet i:695-698.
15. Dröse, S., and K. Altendorf. 1997. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J. Exp. Biol. 200:1-8.
16. Gavilanes, F., J. M. Gonzalez-Ros, and D. L. Peterson. 1982. Structure of hepatitis B surface antigen. Characterization of the lipid components and their association with the viral proteins. J. Biol. Chem. 257:7770-7777.
17. Goldstein, J. L., M. S. Brown, R. G. Anderson, D. W. Russell, and W. J. Schneider. 1985. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu. Rev. Cell Biol. 1:1-39.
18. Holstein, S. A., and R. J. Hohl. 2004. Isoprenoids: remarkable diversity of form and function. Lipids 39:293-309.
19. Horie, M., et al. 1990. NB-598: a potent competitive inhibitor of squalene epoxidase. J. Biol. Chem. 265:18075-18078.
20. Huovila, A. P., A. M. Eder, and S. D. Fuller. 1992. Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment. J. Cell Biol. 118: 1305-1320.
21. Kapadia, S. B., H. Barth, T. Baumert, J. A. McKeating, and F. V. Chisari. 2007. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J. Virol. 81:374-383.
22. Kapadia, S. B., and F. V. Chisari. 2005. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc. Natl. Acad. Sci. U. S. A. 102:2561-2566.
23. Lambert, C., and R. Prange. 2001. Dual topology of the hepatitis B virus large envelope protein: determinants influencing post-translational pre-S translocation. J. Biol. Chem. 276:22265-22272.
24. Lazar, C., et al. 2007. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity. Antiviral Res. 76:30-37.
25. Leser, G. P., and R. A. Lamb. 2005. Influenza virus assembly and budding in raft-derived microdomains: a quantitative analysis of the surface distribution of HA, NA and M2 proteins. Virology 342:215-227.
26. Le Seyec, J., P. Chouteau, I. Cannie, C. Guguen-Guillouzo, and P. Gripon. 1999. Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J. Virol. 73:2052-2057.
27. Lin, Y. L., M. S. Shiao, C. Mettling, and C. K. Chou. 2003. Cholesterol requirement of hepatitis B surface antigen (HBsAg) secretion. Virology 314:253-260.
28. Liscum, L., and N. J. Munn. 1999. Intracellular cholesterol transport. Biochim. Biophys. Acta 1438:19-37.
29. Mabit, H., and H. Schaller. 2000. Intracellular hepadnavirus nucleocapsids are selected for secretion by envelope protein-independent membrane binding. J. Virol. 74:11472-11478.
30. Macovei, A., et al. Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells. J. Virol. 84:243-253.
31. Martin, S., and R. G. Parton. 2006. Lipid droplets: a unified view of a dynamic organelle. Nat. Rev. Mol. Cell Biol. 7:373-378.
32. Martys, J. L., et al. 1996. Wortmannin-sensitive trafficking pathways in Chinese hamster ovary cells. Differential effects on endocytosis and lysosomal sorting. J. Biol. Chem. 271:10953-10962.
33. Maruoka, N., et al. 2007. Effects of chlorpromazine on plasma membrane permeability and fluidity in the rat brain: a dynamic positron autoradiography and fluorescence polarization study. Prog. Neuropsychopharmacol. Biol. Psychiatry 31:178-186.
34. Miyanari, Y., et al. 2007. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 9:1089-1097.
35. Nilsson, I., H. Ohvo-Rekila, J. P. Slotte, A. E. Johnson, and G. von Heijne. 2001. Inhibition of protein translocation across the endoplasmic reticulum membrane by sterols. J. Biol. Chem. 276:41748-41754.
36. Pelham, H. R. 1991. Multiple targets for brefeldin A. Cell 67:449-451.
37. Pollock, S., et al. 2010. Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells. Proc. Natl. Acad. Sci. U. S. A. 107:17176-17181.
38. Popescu, C. I., and J. Dubuisson. Role of lipid metabolism in hepatitis C virus assembly and entry. Biol. Cell 102:63-74.
39. Prange, R., and R. E. Streeck. 1995. Novel transmembrane topology of the hepatitis B virus envelope proteins. EMBO J. 14:247-256.
40. Reaves, B., and G. Banting. 1994. Vacuolar ATPase inactivation blocks recycling to the trans-Golgi network from the plasma membrane. FEBS Lett. 345:61-66.
41. Robinson, W. S., and L. I. Lutwick. 1976. The virus of hepatitis, type B (first of two parts). N. Engl. J. Med. 295:1168-1175.
42. Samsa, M. M., et al. 2009. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog. 5:e1000632.
43. Schulze, A., A. Schieck, Y. Ni, W. Mier, and S. Urban. 2010. Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope proteinmediated receptor interaction. J. Virol. 84:1989-2000.
44. Sells, M. A., M. L. Chen, and G. Acs. 1987. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. U. S. A. 84:1005-1009.
45. Shavinskaya, A., S. Boulant, F. Penin, J. McLauchlan, and R. Bartenschlager. 2007. The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J. Biol. Chem. 282:37158-37169.
46. Straume, M., and B. J. Litman. 1987. Influence of cholesterol on equilibrium and dynamic bilayer structure of unsaturated acyl chain phosphatidylcholine vesicles as determined from higher order analysis of fluorescence anisotropy decay. Biochemistry 26:5121-5126.
47. Takeda, M., G. P. Leser, C. J. Russell, and R. A. Lamb. 2003. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc. Natl. Acad. Sci. U. S. A. 100:14610-14617.
48. Thiele, C., and J. Spandl. 2008. Cell biology of lipid droplets. Curr. Opin. Cell Biol. 20:378-385.
49. Vincent, S., D. Gerlier, and S. N. Manie. 2000. Measles virus assembly within membrane rafts. J. Virol. 74:9911-9915.
50. Yeagle, P. L. 1991. Modulation of membrane function by cholesterol. Biochimie 73:1303-1310.